Artiva Biotherapeutics, Inc. ARTV Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s other income (expense)?
- Artiva Biotherapeutics, Inc. (ARTV) reported other income (expense) of $914K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s other income (expense) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s other income (expense) decreased by 50.9% year-over-year, from $1.86M to $914K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s other income (expense)?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s other income (expense) has grown at a 71.4% compound annual growth rate (CAGR), from $2.02M to $5.95M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.